<DOC>
	<DOCNO>NCT01388608</DOCNO>
	<brief_summary>Data activity daily live patient rheumatoid arthritis assess mainly health assessment questionnaire ( HAQ ) . The HAQ generate data subjective variable . It would desirable advantageous add objective tool reflect patient ' activity outcome parameter rheumatoid arthritis . The StepWatchâ„¢ activity monitor ( SAM ) ankle worn step counter accurate instrument measure real world ambulatory activity . The investigator purpose investigate whether activity daily live measure SAM increase therapy TNF-alpha inhibitor etanercept patient active rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>Standard Disease Activity Parameters Step Activity Patients With Rheumatoid Arthritis Receiving Etanercept</brief_title>
	<detailed_description>In past decade treatment strategy rheumatoid arthritis ( RA ) change dramatically . Today far therapeutic option available . Patients treat earlier aggressive past . These process influence outcome patient RA way evaluate . Outcome variables disease aspect consequence develop course RA . The HAQ score show good predictor patient outcome RA . However , HAQ ist questionnaire score influence subjective factor . The Step Watch Activity monitor ( SAM ) highly accurate accelerometer-based step monitor . The SAM provide detailed profile number step take subject . It small unobtrusive device wear laterally right ankle . It weight 65 gram use 2D accelerometry . The SAM provide objective information activity daily live . Etanercept recombinant fully human TNF-receptor p75-Fc fusion protein . Numerous study etanercept show clinical efficacy . This demonstrate various disease activity score ( e.g DAS28 ) . In addition strong evidence etanercept improve disability measure HAQ . There publication report measure physical activity patient joint disease ; include patient osteoarthritis . Our aim include patient active RA receive etanercept . These patient ask wear SAM 7 day treatment 4 week 12 week initiation therapy etanercept . The step activity measure SAM correlate clinical sore DAS28 HAQ .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Patients active rheumatoid arthritis ( Disease activity score DAS28 &gt; 3.2 ) eligible treatment etanercept . Age 18 old Male female Contraindications therapy etanercept Patients able comply requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>etanercept</keyword>
	<keyword>step activity measure</keyword>
</DOC>